NPI registry status
Active
2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1568625192 M.D.
Verify on CMS → Nikola Ragusa, M.D.
Glaucoma Specialist (Ophthalmology) Physician in Bronx, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 356 in Glaucoma Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 901 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
68%
generic claims · 32% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.5/100
▲ 11 pts above national avg 83.1 · Exceptional
Industry payments
$2.3K
33 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Nikola Ragusa, M.D. reported a CMS MIPS final score of 94.5/100 - above the 83.1 national average - and filed 4,249 Medicare Part D claims in 2023.
- 94.5/100
- MIPS score · +11 vs avg
- 4K
- Part D claims, 2023
- 68%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Nikola Ragusa, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
95 Top 25% higher than 75% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Nikola Ragusa, M.D. sits
This provider among glaucoma specialist (ophthalmology) physician peers
Across the 216 glaucoma specialist (ophthalmology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Nikola Ragusa, M.D. writes more Part D claims than 72% of them and scores higher on MIPS quality than 73% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one glaucoma specialist (ophthalmology) physician peer from a representative sample of 60; the gold marker is Nikola Ragusa, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Nikola Ragusa, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Nikola Ragusa, M.D.?
High performer (top quartile)Primary specialty
Glaucoma Specialist (Ophthalmology) Physician
Medicare Part D claims
4,249 43% vs specialty avg
MIPS final score
94.5/100 11.4 pts vs avg
Specialty distribution in New York
How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Nikola Ragusa, M.D.'s 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average
- MIPS Final Score
- 94.5/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) - 94.5/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Nikola Ragusa, M.D. appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding M.D. credentials at 1625 SAINT PETERS AVE, Bronx, NY, 10461, with a listed phone of (718) 823-9227. NPI 1568625192 was issued on 07/03/2008.
Medicare Part D records for calendar year 2023 show 4,249 prescription claims written by this provider, covering 901 Medicare beneficiaries and totaling roughly $655K in drug spend, split 32% brand-name and 68% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.5/100 for the 2023 performance year (Quality 82.6), compared with the national average of 83.1.
Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 356 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1568625192 |
|---|---|
| Specialty | Glaucoma Specialist (Ophthalmology) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/03/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
94.526
Final Score
Avg: 83.1
82.5927
Quality
97
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Nikola Ragusa, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Gotham Eye Medical P.C.
Bronx, NY
Michael A Pisacano MD PC
Bronx, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Nikola Ragusa, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.3K
Largest payer
NEW WORLD MEDICAL,INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Nikola Ragusa, M.D.. To verify Nikola Ragusa, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Nikola Ragusa, M.D. - brand share 32.0%
Glaucoma Specialist (Ophthalmology) Physician average
32% brand-name claims vs 68% generic, on 4,249 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,249
Total Claims
$655K
Total Drug Cost
901
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 7,407
- Total Day Supply
- 215,142
- Brand vs Generic
- 32% brand / 68% generic
- Brand Drug Cost
- $561K
- Generic Drug Cost
- $94K
- Antibiotic Claims
- 20
Patient Demographics
- Average Patient Age
- 74.0 years
- Avg HCC Risk Score
- 1.38
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 67, 65-74: 439, 75-84: 286, 85+: 109
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Nikola Ragusa, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
1,399 claims
- Dorzolamide-Timolol 377
Dorzolamide-Timolol
377 claims
- Prednisolone Acetate 329
Prednisolone Acetate
329 claims
- Brimonidine Tartrate 310
Brimonidine Tartrate
310 claims
- Ketorolac Trometha… 230
Ketorolac Tromethamine
230 claims
- Xiidra 208
Xiidra
208 claims
- Olopatadine Hcl 205
Olopatadine Hcl
205 claims
- Ofloxacin 199
Ofloxacin
199 claims
| Drug | Claims |
|---|---|
| Latanoprost | 1,399 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 377 |
| Prednisolone Acetate | 329 |
| Brimonidine Tartrate | 310 |
| Ketorolac Tromethamine | 230 |
| Xiidra Lifitegrast | 208 |
| Olopatadine Hcl | 205 |
| Ofloxacin | 199 |
| Rhopressa Netarsudil Mesylate | 107 |
| Dorzolamide Hcl | 102 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Glaucoma Specialist (Ophthalmology) Physician in NY →
All providers in New York →
Compare specialties →
Glaucoma Specialist (Ophthalmology) Physician Overview
How Nikola Ragusa, M.D. fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.
356
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider
Nikola Ragusa, M.D.'s 4,249 claims are above the specialty average of 2,962.
Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Ragusa.
Dr. Farihah Anwar
M.D.
Bethpage, NY
Dr. Dana Blumberg
MD
New York, NY
Dr. Zoya Chaudhry
MD
New York, NY
Dr. Tony Choi
M.D.
Pomona, NY
Dr. George Cioffi
MD
New York, NY
Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Glaucoma Specialist (Ophthalmology) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Nikola Ragusa, M.D.'s specialty? ▼
Nikola Ragusa, M.D. specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in Bronx, New York. Credentials: M.D..
How much does Nikola Ragusa, M.D. prescribe under Medicare Part D? ▼
In 2023, Nikola Ragusa, M.D. wrote 4,249 Medicare Part D claims totaling $655K in drug costs for 901 beneficiaries.
What is Nikola Ragusa, M.D.'s Medicare quality score? ▼
Nikola Ragusa, M.D. has a CMS MIPS Final Score of 94.5/100 (Quality: 82.6). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Nikola Ragusa, M.D. located? ▼
Nikola Ragusa, M.D. is located at 1625 SAINT PETERS AVE, Bronx, NY, 10461. Phone: (718) 823-9227.
What is Nikola Ragusa, M.D.'s NPI number? ▼
Nikola Ragusa, M.D.'s National Provider Identifier (NPI) is 1568625192, issued on 07/03/2008.
Does Nikola Ragusa, M.D. prescribe more brand-name or generic drugs? ▼
Nikola Ragusa, M.D.'s prescribing is 32% brand-name and 68% generic drugs by claim count, with $561K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US? ▼
There are 356 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does Nikola Ragusa, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Nikola Ragusa, M.D.'s most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Nikola Ragusa, M.D. accept Medicare? ▼
Nikola Ragusa, M.D. appears in CMS Medicare data with 4,249 Part D claims and 901 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Nikola Ragusa, M.D.'s credentials? ▼
Nikola Ragusa, M.D.'s NPI is 1568625192 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.